Celesio sells Anzag shareholding to Alliance Boots
Celesio AG has sold its 14.15 per cent shareholding in the Frankfurt-based pharmaceutical wholesaler Andreae-Noris Zahn AG (Anzag). The 1,510,900 shares have been purchased by the British pharmaceutical distributor Alliance Boots. The agreed price per Anzag share is 26.00 euro. Celesio will use the proceeds from the sale, amounting to about 39.3 million euro, to decrease its liabilities.
The Celesio Management Board took the decision in June 2010 to sell its shareholding in the Frankfurt-based pharmaceutical wholesaler, which is no longer deemed to be strategic. Celesio had held a shareholding in Anzag since 2003.
The sale is still to be approved by the appropriate competition authorities.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.